CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing

SF3B1 is the most frequently mutated splicing factor in cancer. Mutations in SF3B1 likely confer clonal advantages to cancer cells but they may also confer vulnerabilities that can be therapeutically targeted. SF3B1 cancer mutations can be maintained in homozygosis in C. elegans, allowing synthetic...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS Genet
Huvudupphovsmän: Serrat, Xènia, Kukhtar, Dmytro, Cornes, Eric, Esteve-Codina, Anna, Benlloch, Helena, Cecere, Germano, Cerón, Julián
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6830814/
https://ncbi.nlm.nih.gov/pubmed/31634348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1008464
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk